The Federal Court considered patent validity, claim construction, infringement, and remedies in a dispute between Adeia Guides Inc. and Videotron Ltd. over interactive television technologies.
The Court affirmed the Federal Court’s purposive construction limiting 'manufacturer code' and 'device class' to their ISO meanings, found those parameters and the microprocessor location to be essential based on the disclosure and lack of contrary expert evidence, held the CanPlug and FarmCommand did not include the essential ISO parameters so did not infringe, and concluded the '742 Patent is invalid because the GreenStar 3 anticipated the device claims and the remaining device and system claims were obvious in light of ISO and the common general knowledge; accordingly the appeals were dism…
The Federal Court construed key patent terms in McCain’s potato-processing patent, found Simplot’s PEF process outside the claims, and dismissed the action.
Federal Court upheld Alexion’s 810 Patent, finding Amgen failed to prove anticipation or obviousness and granting infringement relief for BEKEMV eculizumab.
Anticipation
Obviousness
Claims construction
Injunction
Delivery up/destroy
Patent medicines (notice of compliance) regulations
The Federal Court’s factual findings and credibility assessments supported its conclusions that the asserted claims were disclosed, anticipated or rendered obvious by the prior art; the appellants failed to show any palpable and overriding error or legal error in the Federal Court’s application of disclosure, anticipation and obviousness law, therefore the appeal is dismissed.
The Court dismissed Munchkin's appeal and upheld the Federal Court's findings on anticipation, obviousness and Munchkin, Inc.'s liability (noting a non-outcome-determinative error excluding Diaper Genie II from CGK). The Court allowed Angelcare's appeal: it concluded Munchkin's Generation 4 product infringes claims 9 and 10 of CA 2,640,384 and claims 1, 16, 17, 18, 19 and 20 of CA 2,855,159, amended the Federal Court judgment accordingly, and granted the permanent injunction and costs to Angelcare.
The Federal Court found no infringement of ProSlide’s asserted patents by WhiteWater’s AquaSphere, Orbiter, or Tailspin, and held several asserted claims invalid.
The Federal Court correctly held that the asserted claims of the 021 Patent were neither anticipated nor obvious: the cited prior patents did not disclose that flucarbazone sodium possessed the claimed selective herbicidal properties nor enable its claimed use (particularly for cereals/wheat), and the Federal Court applied the correct legal tests claim-by-claim and under the appropriate standard of review, so the appeals are dismissed.
The Federal Court construed Molo’s patent for flexible partitions, found Chanel’s honeycomb paper products lacked the claimed supports, and held key claims invalid for anticipation or obviousness.
Federal Court found the 083 Patent valid and infringed for nintedanib IPF use, but held the 267 Patent not infringed because lecithin was essential and absent from JAMP’s product.